Cell and gene therapies have moved from promise to reality.
Many firms have built substantial franchises, but there is still great unmet need and the potential to displace and disrupt existing therapies.
Research and development of cell therapies and gene therapies continue to grow quickly, and regulatory oversight is paramount to continued sector success.
Cell & Gene's expert content offers readers a exploration into the opportunities and challenges across cell and gene therapy modalities coming to market including technical challenges, licensing, unique supply chain demands, adoption and reimbursement in healthcare systems and public or patient attitudes to this medical revolution.
Register for our newsletter today.
Sign Up Today
About Cell & Gene
Cell & Gene provides actionable information to professionals involved in the development and commercialization of cell and gene
therapies. Through the original editorial published on the site — both staff-written and contributed (by subject-matter experts) — Cell &
Gene facilitates the sharing of insights on challenges, trends, and best practices in this burgeoning field. Cell & Gene’s editorial scope
spans the entire product lifecycle from basic research to commercialization.